Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of BHCHX's 40 holdings also in IXJ
16.1%
% of IXJ's 114 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BHCHX |
Weight in IXJ |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY AND COMPANY | 9.3% | 8.5% | 8.5% |
|
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 5.1% | 5.1% |
|
MERCK & CO., INC. | 4.8% | 2.8% | 2.8% |
|
INTUITIVE SURGICAL, INC. | 5.8% | 2.8% | 2.8% |
|
THERMO FISHER SCIENTIFIC INC | 4.7% | 2.3% | 2.3% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to IXJ
 |
ARGENX SE ADR | 4.1% |
 |
ICON PLC | 3.2% |
|
BOSTON SCIENTIFIC CORPORATION | 3.1% |
|
BOSTON SCIENTIFIC CORP | 3.1% |
|
INTUITIVE SURGICAL, INC. | 3.0% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 3.0% |
|
VERTEX PHARMACEUTICALS INCORPORATED | 3.0% |
|
ARCELLX, INC. | 2.6% |
|
THERMO FISHER SCIENTIFIC INC | 2.4% |
BHCHX Underweight Relative to IXJ
|
JOHNSON & JOHNSON | -5.4% |
|
ABBVIE INC | -4.7% |
|
ABBOTT LABORATORIES | -3.4% |
 |
ROCHE HOLDING LTD | -3.2% |
|
NOVARTIS AG | -3.2% |
 |
ASTRAZENECA PLC | -3.1% |
 |
NOVO NORDISK A/S-B | -3.1% |
|
AMGEN INC | -2.1% |
|
PFIZER INC | -1.8% |
|
GILEAD SCIENCES INC | -1.8% |